Dear NONMEM users,
Last days to apply for PhD research fellowship: Pharmacometrics & Computational Disease Modelling in Berlin/Potsdam! ********************************** The Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling is an interdisciplinary PhD program bridging pharmacy and mathematics. The PharMetrX program comprises an excellent research environment in the vibrant Berlin/Potsdam area, fascinating and innovative research projects in a highly relevant field, truely transdisciplinary supervision, an individual mentorship from one of the industry partners and a highly competitive 3.5 year fellowship. In addition, PharMetrX offers a specifically tailored training curriculum and a network of peers, both of which are also open for external PhD students from other universities. We are currently inviting applications to start the PharMetrX PhD program in March 2018. PharMetrX is open to candidates with a university degree in pharmacy, mathematics/statistics, bioinformatics, natural sciences or medicine. Deadline for applications: September 15th, 2017. For details see <https://www.PharMetrX.de> https://www.PharMetrX.de. PharMetrX is a joint program of the Freie Universität Berlin and the Universität Potsdam, supported by several global research-driven pharmaceutical companies. Charlotte Kloft & Wilhelm Huisinga Program Chairs Kind regards --------------------------------------------------------------------- Cornelia Böhnstedt Program Coordinator Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling at the Freie Universität Berlin and the Universität Potsdam E-mail: <mailto:cornelia.boehnst...@fu-berlin.de> cornelia.boehnst...@fu-berlin.de Phone: +49 (030) 838-51726 Office hours: Mon 08:00 15:30 / Tue 08:00 15:30 / Thu 08:00 15:30 - In between flexible working hours - <http://www.clinical-pharmacy.eu/> www.clinical-pharmacy.eu <http://www.pharmetrx.de/> www.PharMetrX.de --------------------------------------------------------------------